Current and future challenges in therapy for antibody-mediated rejection.

Current and future challenges in therapy for antibody-mediated rejection.

Item
http://www.wikidata.org/entity/Q37862862
Exercise-based cardiac rehabilitation in heart transplant recipientsImmunologic considerations in heart transplantation for congenital heart diseaseInduction therapy in heart transplantation: where are we now?The Complement System and Antibody-Mediated Transplant RejectionAntibody-mediated rejection: an evolving entity in heart transplantation.Exercise-based cardiac rehabilitation in heart transplant recipients.Alloantibody and complement promote T cell-mediated cardiac allograft vasculopathy through noncanonical nuclear factor-κB signaling in endothelial cells.Heart transplantation research in the next decade--a goal to achieving evidence-based outcomes: National Heart, Lung, And Blood Institute Working GroupSignificance of Anti-HLA Antibodies on Adult and Pediatric Heart Allograft Outcomes.Heart transplantation: challenges facing the field.Improving survival during heart transplantation: diagnosis of antibody-mediated rejection and techniques for the prevention of graft injury.Rituximab is associated with improved survival in cardiac allograft patients with antibody-mediated rejection: a single center review.Human leukocyte antigens and alloimmunization in heart transplantation: an open debate.Immunosuppression and adult heart transplantation: emerging therapies and opportunities.Permanent CNI treatment for prevention of renal allograft rejection in sensitized hosts can be replaced by regulatory T cells.C4d immunostaining is an independent predictor of cardiac allograft vasculopathy and death in heart transplant recipients.A survey of current practice for antibody-mediated rejection in heart transplantation.
P2860

Current and future challenges in therapy for antibody-mediated rejection.

Item
http://www.wikidata.org/entity/Q37862862
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 April 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Current and future challenges in therapy for antibody-mediated rejection.
@en
Current and future challenges in therapy for antibody-mediated rejection.
@nl
type
label
Current and future challenges in therapy for antibody-mediated rejection.
@en
Current and future challenges in therapy for antibody-mediated rejection.
@nl
prefLabel
Current and future challenges in therapy for antibody-mediated rejection.
@en
Current and future challenges in therapy for antibody-mediated rejection.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P356
P1433
P1476
Current and future challenges in therapy for antibody-mediated rejection.
@en
P2093
P304
P31
P356
10.1016/J.HEALUN.2011.02.002
P433
P478
P50
P577
P5875
P698
P921